BRPI0520168A2 - mimeticorpos de glp-1 humanos, composiÇÕes, mÉtodos e usos - Google Patents
mimeticorpos de glp-1 humanos, composiÇÕes, mÉtodos e usosInfo
- Publication number
- BRPI0520168A2 BRPI0520168A2 BRPI0520168-3A BRPI0520168A BRPI0520168A2 BR PI0520168 A2 BRPI0520168 A2 BR PI0520168A2 BR PI0520168 A BRPI0520168 A BR PI0520168A BR PI0520168 A2 BRPI0520168 A2 BR PI0520168A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- glp
- compositions
- mimetibody
- mimetibodies
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 101100337060 Caenorhabditis elegans glp-1 gene Proteins 0.000 title 1
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 abstract 2
- 102100025101 GATA-type zinc finger protein 1 Human genes 0.000 abstract 2
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 abstract 2
- 101000788682 Homo sapiens GATA-type zinc finger protein 1 Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000009261 transgenic effect Effects 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2318/00—Antibody mimetics or scaffolds
- C07K2318/10—Immunoglobulin or domain(s) thereof as scaffolds for inserted non-Ig peptide sequences, e.g. for vaccination purposes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2005097175 | 2005-03-28 | ||
| PCT/US2005/046884 WO2007081302A2 (en) | 2005-03-28 | 2005-12-22 | Human glp-1 mimetibodies, compositions, methods and uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0520168A2 true BRPI0520168A2 (pt) | 2009-04-22 |
Family
ID=38256744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0520168-3A BRPI0520168A2 (pt) | 2005-03-28 | 2005-12-22 | mimeticorpos de glp-1 humanos, composiÇÕes, mÉtodos e usos |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1871811A4 (enExample) |
| JP (1) | JP2008546373A (enExample) |
| KR (1) | KR20080005378A (enExample) |
| CN (1) | CN101389346A (enExample) |
| AU (1) | AU2005339797A1 (enExample) |
| BR (1) | BRPI0520168A2 (enExample) |
| CA (1) | CA2603359A1 (enExample) |
| CR (1) | CR9481A (enExample) |
| IL (1) | IL186307A0 (enExample) |
| MX (1) | MX2007011975A (enExample) |
| NO (1) | NO20075272L (enExample) |
| WO (1) | WO2007081302A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200843794A (en) * | 2006-12-21 | 2008-11-16 | Centocor Inc | Use of long-acting GLP-1 receptor agonists to improve insulin sensitivity and lipid profiles |
| CN111574583B (zh) * | 2020-04-10 | 2021-06-25 | 上海海路生物技术有限公司 | 蛋白复性试剂及其应用 |
| CN120741086A (zh) * | 2024-07-26 | 2025-10-03 | 荣耀终端股份有限公司 | 模拟人体组织液及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000046380A2 (en) * | 1999-02-08 | 2000-08-10 | Chiron Corporation | Fibroblast growth factor receptor-immunoglobulin fusion |
| NZ525577A (en) * | 2000-12-07 | 2005-05-27 | Lilly Co Eli | Glucagon-Like Peptide 1 heterologous fusion proteins for the treatment of non-insulin dependent diabetes mellitus |
| JP2006504406A (ja) * | 2002-06-28 | 2006-02-09 | セントカー・インコーポレーテツド | 哺乳動物のｃｈ１欠失ミメティボディ、組成物、方法および使用 |
| AU2003256336A1 (en) * | 2002-06-28 | 2004-01-19 | Centocor, Inc. | Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| EP1644416A4 (en) * | 2003-06-30 | 2007-08-29 | Centocor Inc | ANTI-TARGET AND GENETICALLY MODIFIED IMMUNOGLOBULIN-DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES |
| AU2005231359A1 (en) * | 2004-03-31 | 2005-10-20 | Centocor, Inc. | Human GLP-1 mimetibodies, compositions, methods and uses |
-
2005
- 2005-12-22 EP EP05858723A patent/EP1871811A4/en not_active Withdrawn
- 2005-12-22 MX MX2007011975A patent/MX2007011975A/es not_active Application Discontinuation
- 2005-12-22 CN CNA200580049931XA patent/CN101389346A/zh active Pending
- 2005-12-22 JP JP2008504018A patent/JP2008546373A/ja active Pending
- 2005-12-22 AU AU2005339797A patent/AU2005339797A1/en not_active Abandoned
- 2005-12-22 KR KR1020077024874A patent/KR20080005378A/ko not_active Withdrawn
- 2005-12-22 BR BRPI0520168-3A patent/BRPI0520168A2/pt not_active Application Discontinuation
- 2005-12-22 CA CA002603359A patent/CA2603359A1/en not_active Abandoned
- 2005-12-22 WO PCT/US2005/046884 patent/WO2007081302A2/en not_active Ceased
-
2007
- 2007-09-25 IL IL186307A patent/IL186307A0/en unknown
- 2007-10-15 NO NO20075272A patent/NO20075272L/no not_active Application Discontinuation
- 2007-10-29 CR CR9481A patent/CR9481A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007081302A3 (en) | 2008-11-13 |
| CN101389346A (zh) | 2009-03-18 |
| EP1871811A4 (en) | 2009-07-22 |
| EP1871811A2 (en) | 2008-01-02 |
| AU2005339797A1 (en) | 2007-07-19 |
| NO20075272L (no) | 2007-12-28 |
| KR20080005378A (ko) | 2008-01-11 |
| CR9481A (es) | 2009-01-14 |
| MX2007011975A (es) | 2008-03-14 |
| WO2007081302A2 (en) | 2007-07-19 |
| CA2603359A1 (en) | 2007-07-19 |
| JP2008546373A (ja) | 2008-12-25 |
| IL186307A0 (en) | 2008-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0509528A (pt) | corpos imitação de glp-1 humana, composições, processos e usos | |
| ECSP099079A (es) | Mimeticuerpos de peptido-1 similar a glucagon de humano, composiciones, metodos y usos | |
| WO2007046834A3 (en) | Glp-1 agonists, compositions, methods and uses | |
| ECSP066466A (es) | Mimeticuerpos humanos centrales de la region de bisagra, mimeticos de la eritropoyetina, composiciones, metodos y usos | |
| CR9606A (es) | Anticuerpos anti-proteina quinoatrayente de monocitos-1, composiciones, metodos y usos | |
| HN2006016512A (es) | Anticuerpos anti-il-6, composiciones, metodos y usos | |
| MX2017004814A (es) | Polipeptidos insecticidas que tienen un espectro de actividad mejorado y sus usos. | |
| WO2004002417A3 (en) | Mammalian ch1 deleted mimetibodies, compositions, methods and uses | |
| AR078964A1 (es) | Gen de bacillus thuringiensis que codifica polipeptido con actividad pesticida contra lepidoptera | |
| BR0312276A (pt) | Mimeticorpos ch1-removidos miméticos de epo de mamìfero, composições, métodos e usos | |
| WO2005081687A3 (en) | Human hinge core mimetibodies, compositions, methods and uses | |
| BR112019002586A2 (pt) | proteínas inseticidas | |
| WO2008080042A3 (en) | Use of long-acting glp-1 receptor agonists to improve insulin sensitivity and lipid profiles | |
| CR11434A (es) | Anticuerpos anti-amiloide humanos; composiciones, metodosy usos | |
| AR060565A1 (es) | Vacuna para la gripe aviaria y metodos de uso | |
| BRPI1012078A2 (pt) | construto de proteína, composição imunogênica, molécula de ácido nucleico , métodos de induzir uma resposta imune a casb7439 e de tratar um animal humano ou não-humano, e, uso de uma composição imunogênica | |
| BRPI0520168A2 (pt) | mimeticorpos de glp-1 humanos, composiÇÕes, mÉtodos e usos | |
| WO2007076319A3 (en) | Human glp-1 mimetibodies and compositions for treating obesity and related disorders, methods and uses | |
| WO2009014382A3 (en) | Cxcl11 adjuvant compositions and uses thereof | |
| AR063427A1 (es) | Proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal | |
| BR112019008284A2 (pt) | proteínas inseticidas | |
| GT200700100A (es) | (s)-n-metilnatrexona | |
| BRPI0705784A2 (pt) | usos de uma composição contendo um biofármaco expressando a proteìna de choque térmico hsp65 de micobactérias | |
| BRPI0820263A2 (pt) | Métodos para intensificação de características relacionadas ao redimentos em plantas com relação a plantas de controle e para a produção de uma planta transgênica tendo rendimento aumentado, molécula de ácido nucleico isolada, polipeptídeo isolado, construto, uso de um construto, planta, parte de planta ou célula de planta, planta trangênica, partes colhíveis de uma planta, produtos, e, uso de um ácido nucleico que codifica um polipeptídeo de patelina, prp38, ada2,... | |
| WO2007070996A3 (en) | Liga and ligb proteins (leptospiral ig-like (lig) domains) for vaccination and diagnosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: JOHNSON AND JOHNSON (US) Free format text: TRANSFERIDO DE: CENTOCOR, INC. |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
| B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |